Your session is about to expire
← Back to Search
Neurologic Music Therapy for Parkinson's Disease
Study Summary
This trial will test whether Neurologic Music Therapy can help improve fine motor movements for adults with Parkinson's Disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot move my fingers or hands.My Parkinson's symptoms are not due to a stroke or major head injury.My Parkinson's disease is in an advanced stage.My insurance does not cover Occupational Therapy, or I am uninsured.I have difficulty with tasks that require small, precise movements.I am between 45 and 85 years old.I have been diagnosed with dementia.
- Group 1: Neurologic Music Therapy (NMT)
- Group 2: Occupational Therapy (OT)
- Group 3: Waitlist Control
- Group 4: Music Supported Therapy (MST)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacant spots available for participation in this research?
"Affirmative. According to the clinicaltrials.gov listing, this experiment is actively recruiting participants since it was first published on April 26th 2017 and most recently edited on January 19th 2022. The researchers are looking for 100 test subjects from a single medical centre."
What is the ultimate aim of this experiment?
"This clinical trial will be conducted over a Baseline and 5 week period, with the primary Quality of Life (QOL) Outcome being an assessment of change in the 39-Item Parkinson's disease. Secondary QOL outcomes include evaluations of changes in Hospital Anxiety and Depression Scale as well as Clinical Global Impression - Improvement Scale. The second motor outcome for this study is an analysis of Unified Parkinson disease Rating Scale Part III variation."
What steps do I need to take in order to participate in this experiment?
"In order to join this clinical trial, participants must possess parkinson disease and be between the ages of 45 and 85. This particular research endeavour is enrolling a total of 100 volunteers."
How many participants are being recruited for this clinical trial?
"Affirmative. Clinicaltrials.gov has data that confirms recruitment for the clinical trial, which was first introduced on April 26th 2017 and most recently revised January 19th 2022. The aim is to find 100 patients from one medical centre."
Is this research protocol allowing those aged 45 and above to participate?
"To participate in this trial, patients must be between 45 and 85 years old. Additionally, there are 27 trials for those under 18 and 485 for those over the age of 65."
Share this study with friends
Copy Link
Messenger